HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. (HTGMQ) Revenue
Annual & quarterly revenue history · segment & region breakdown
HTGMQ · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHTG Molecular Diagnostics, Inc. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 28.52% year-over-year from $0.01B in FY2022.
Revenue trend
2022 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.01B | -$0.00B | -28.52% |
| 2021-12-31 | $0.01B | +$0.00B | +4.19% |
| 2020-12-31 | $0.01B | -$0.01B | -55.48% |
| 2019-12-31 | $0.02B | -$0.00B | -10.70% |
| 2018-12-31 | $0.02B | +$0.01B | +45.69% |
| 2017-12-31 | $0.01B | +$0.01B | +187.56% |
| 2016-12-31 | $0.01B | +$0.00B | +27.00% |
| 2015-12-31 | $0.00B | +$0.00B | +21.41% |
| 2014-12-31 | $0.00B | +$0.00B | +48.41% |
| 2013-12-31 | $0.00B | -$0.00B | -9.58% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income HTG Molecular Diagnostics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
HTG Molecular Diagnostics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from HTG Molecular Diagnostics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HTGMQ revenue · 4 questionsHTGMQ's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 28.52% year-over-year from $0.01B in FY2022.
▸ Source: FMP · HTG Molecular Diagnostics, Inc. SEC filings · GAAP · HTG Molecular Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026